Signaling Diversity Among Gqa Family Members

体现 Gqa 家族成员的多样性

基本信息

  • 批准号:
    6370836
  • 负责人:
  • 金额:
    $ 26.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-02 至 2005-06-30
  • 项目状态:
    已结题

项目摘要

Many hormones and neurotransmitters rely on the Gq class of heterotrimeric G proteins (Gq/11alpha, G14alpha, and G15/16alpha) to exert their actions at target issues. Gqalpha family members activate PLCbeta and inositol lipid signaling, and established models suggest that the cellular actions of these Galpha are identical and result from activation of Ca PKC pathways. However compelling evidence now indicated that Gq/11alpha, G14alpha, and G15/16alpha differ markedly in their overall cellular responses, their interactions with certain protein binding partners, and their cellular and biochemical properties. Contrary to established models, my working hypothesis is that Gq/11alpha, G14alpha and G15/16alpha regulate multiple overlapping and distinct signaling cascades, and are regulated differently by host cells to elicit a distinct profile of cellular responses. Consistent with this idea, Gqalph family members are expressed in different cells, and Gqalpha interacts with multiple signaling proteins besides PLCbeta, though the relative contribution of each binding partner to Gqalpha signaling is unknown. Furthermore, Gq/11alpha, G14alpha and G15/16alpha share only 57 percent overall amino acid identity, and just 12 percent identity within their first 35 residues (N- terminus) which contains fatty acids that are essential for regulating Galpha signaling capacity. Although the acylation state of G14alpha and G15/16alpha is unknown, sequence alignments predict that Gqalpha family members are modified differently. Using modem molecular, cellular, and biochemical approaches study G protein functions, the specific aims will be to: 1. Define biochemical modifications present on Gq/11alpha, G14alpha, and G15/16alpha important for regulating signaling functions. 2. Define factors that regulate Gq/11alpha, G14alpha and G15/16alpha signaling capacity including target subcelluar localization and interactions with protein binding partners. 3. Determine the diversity of cell signaling responses elicited by Gqalpha, G14alpha and G15/16alpha in selected cells, and the relative contribution of Galpha binding partners to those responses. Heterotrimeric G proteins serve essential roles in cell physiology by inking cell surface receptors to intracellular responses. G protein dysfunction is the direct cause of a growing list of human diseases, and the majority of currently available drugs exert their actions on G protein signaling pathways. These experiments will determine functional correlates for the biochemical differences observed among the Gqalpha family of G proteins, and offer new insights into the diversity and regulation of signaling responses elicited by these important G proteins. Information gained from these studies will help us to better understand G proteins as therapeutic targets.
许多激素和神经递质依赖于Gq类异源三聚体G蛋白(Gq/11 α,G14 α和G15/16 α)在靶点发挥作用。 Gq α家族成员激活PLC β和肌醇脂质信号传导,并且建立的模型表明这些G α的细胞作用是相同的,并且是由Ca PKC途径激活引起的。 然而,现在令人信服的证据表明,Gq/11 α,G14 α和G15/16 α在它们的整体细胞反应,它们与某些蛋白质结合伴侣的相互作用以及它们的细胞和生化特性方面显着不同。 与已建立的模型相反,我的工作假设是Gq/11 α,G14 α和G15/16 α调节多个重叠和不同的信号级联,并由宿主细胞不同地调节,以引起不同的细胞反应谱。 与这一想法一致,Gqalph家族成员在不同的细胞中表达,并且Gqalpha与除了PLC β之外的多种信号传导蛋白相互作用,尽管每个结合伴侣对Gqalpha信号传导的相对贡献是未知的。 此外,Gq/11 α、G14 α和G15/16 α仅共享57%的总体氨基酸同一性,并且在它们的前35个残基(N-末端)内仅共享12%的同一性,所述前35个残基含有对于调节G α信号传导能力至关重要的脂肪酸。 虽然G14 α和G15/16 α的酰化状态是未知的,但序列比对预测Gq α家族成员的修饰不同。本论文运用现代分子、细胞和生物化学方法研究G蛋白的功能,具体目的是:1。定义存在于Gq/11 α,G14 α和G15/16 α上的对调节信号功能重要的生化修饰。2.定义调节Gq/11 α、G14 α和G15/16 α信号传导能力的因素,包括靶向亚细胞定位和与蛋白质结合伴侣的相互作用。3.确定Gq α、G14 α和G15/16 α在选定细胞中引发的细胞信号传导反应的多样性,以及Gq α结合配偶体对这些反应的相对贡献。异源三聚体G蛋白通过将细胞表面受体与细胞内反应联系起来在细胞生理学中起重要作用。 G蛋白功能障碍是越来越多的人类疾病的直接原因,目前大多数可用的药物都对G蛋白信号通路发挥作用。 这些实验将确定G蛋白的Gqalpha家族之间观察到的生化差异的功能相关性,并提供新的见解的多样性和调节这些重要的G蛋白引起的信号反应。 从这些研究中获得的信息将有助于我们更好地了解G蛋白作为治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN R HEPLER其他文献

JOHN R HEPLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN R HEPLER', 18)}}的其他基金

Decoding the RGS14 Interactome/Signalosome in CA2 hippocampal neurons
解码 CA2 海马神经元中的 RGS14 Interactome/Signalosome
  • 批准号:
    9021004
  • 财政年份:
    2015
  • 资助金额:
    $ 26.4万
  • 项目类别:
Exploring RGS14 signaling functions in the CA2 hippocampus
探索 CA2 海马中的 RGS14 信号传导功能
  • 批准号:
    8250157
  • 财政年份:
    2011
  • 资助金额:
    $ 26.4万
  • 项目类别:
Exploring RGS14 signaling functions in the CA2 hippocampus
探索 CA2 海马中的 RGS14 信号传导功能
  • 批准号:
    8322591
  • 财政年份:
    2011
  • 资助金额:
    $ 26.4万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7460544
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7860719
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7142629
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7261259
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
RGS Protein Regulation of G Protein Coupled Receptors
G 蛋白偶联受体的 RGS 蛋白调节
  • 批准号:
    7635827
  • 财政年份:
    2006
  • 资助金额:
    $ 26.4万
  • 项目类别:
Signaling Diversity Among Gqa Family Members
体现 Gqa 家族成员的多样性
  • 批准号:
    6520320
  • 财政年份:
    2001
  • 资助金额:
    $ 26.4万
  • 项目类别:
Signaling Diversity Among Gqa Family Members
体现 Gqa 家族成员的多样性
  • 批准号:
    6769560
  • 财政年份:
    2001
  • 资助金额:
    $ 26.4万
  • 项目类别:

相似海外基金

Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
  • 批准号:
    BB/Y003756/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
  • 批准号:
    MR/Y503435/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
  • 批准号:
    10561406
  • 财政年份:
    2023
  • 资助金额:
    $ 26.4万
  • 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
  • 批准号:
    22KJ1113
  • 财政年份:
    2023
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
  • 批准号:
    BB/X001504/1
  • 财政年份:
    2023
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
  • 批准号:
    10584620
  • 财政年份:
    2022
  • 资助金额:
    $ 26.4万
  • 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
  • 批准号:
    576016-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
  • 批准号:
    10657417
  • 财政年份:
    2022
  • 资助金额:
    $ 26.4万
  • 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
  • 批准号:
    10389517
  • 财政年份:
    2022
  • 资助金额:
    $ 26.4万
  • 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
  • 批准号:
    RGPIN-2019-07122
  • 财政年份:
    2022
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了